Krilogy Financial LLC bought a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 15,694 shares of the company’s stock, valued at approximately $982,000. Several other institutional investors and hedge funds also recently […]